Do not hesitage to give us a call. We are an expert team and we are happy to talk to you.
Travel to Saudi Arabia via Qatar. Seaman Tours has now started Quarantine package through Qatar who have been to India for a vacation and been trying to be back to their work in Saudi Arabia. Qatar having good relationship with Saudi Arabia and being one of the GCC countries have opened their borders for visitors from Qatar after they complete 14 days Quarantines.
Qatar tourist visa has been opened for tourists from India and various other countries.
Travel Saudi via Qatar (Doha)
July, August 2021
Seaman Tours will help you reach your final destination after completing 14 days quarantine in Qatar. Qatar has opened door for tourist from India. The visa will be on arrival with certain conditions like hotel voucher which has to be presented when you arrive Doha. There will be a PCR test which the passenger has to pay in Qatar airport which will be approximate QR 300 (INR 6000). We will help you with EHTERAZ support once you complete your PCR test.
Seaman Tours has been doing quarantine packages successfully for the last 6-8 months ever since the coronavirus pandemic started. We started out with the Dubai quarantine packages and evolved with the fast changing nature of the current travel environment to provide you with the next quarantine destination.
EHTERAZ is an application for obtaining the on arrival approval. The passenger has to do the PCR test valid for 72 hours. Once the result is negative we will have to upload it in the portal and get the approval before travelling. We advise costumers to get approval before booking ticket.
Food will be very basic and will be served on parcel kits with limited options.
There will be 2 PCR done. 1 upon arrival and 2rd one after completing your quarantine. The second PCR will be included in our package
Qatar has confirmed that passenger who has taken 2 doses of approved vaccination and completed 14 days after the vaccination are eligible to obtain on arrival visa in Qatar.
Approved Vaccinations are as follows
Pfizer-BioNTech/Moderna/AstraZeneca/Johnson & Johnson/Covishield